-transparent.png){kind=logo}
Early clinical application of technetium 99m labeled pyrophosphate for cardiac imaging has revealed a safe noninvasive method of determining areas of impaired myocardial perfusion in patients with atherosclerotic occlusive coronary artery disease. Using this method, we were able to demonstrate improvement in myocardial blood supply following coronary artery bypass surgery.
Related Publications
J E Liddicoat, and
S M Bekassy, and
P C Johnson, and
S K Ajmani, and
M E DeBakey
April 1978,
L'union medicale du Canada,
J E Liddicoat, and
S M Bekassy, and
P C Johnson, and
S K Ajmani, and
M E DeBakey
May 1981,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J E Liddicoat, and
S M Bekassy, and
P C Johnson, and
S K Ajmani, and
M E DeBakey
December 1978,
The Journal of the Medical Society of New Jersey,
J E Liddicoat, and
S M Bekassy, and
P C Johnson, and
S K Ajmani, and
M E DeBakey
April 1981,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J E Liddicoat, and
S M Bekassy, and
P C Johnson, and
S K Ajmani, and
M E DeBakey
February 1985,
Clinical nuclear medicine,
J E Liddicoat, and
S M Bekassy, and
P C Johnson, and
S K Ajmani, and
M E DeBakey
October 1988,
Cardiologia (Rome, Italy),
J E Liddicoat, and
S M Bekassy, and
P C Johnson, and
S K Ajmani, and
M E DeBakey
May 1979,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J E Liddicoat, and
S M Bekassy, and
P C Johnson, and
S K Ajmani, and
M E DeBakey
April 1982,
Connecticut medicine,
J E Liddicoat, and
S M Bekassy, and
P C Johnson, and
S K Ajmani, and
M E DeBakey
March 1978,
Ugeskrift for laeger,
J E Liddicoat, and
S M Bekassy, and
P C Johnson, and
S K Ajmani, and
M E DeBakey
April 1975,
Kaku igaku. The Japanese journal of nuclear medicine,
